We are pleased to announce that Boston Healthcare is now a part of Veranex, a new global solutions provider for MedTech and Life Sciences innovators. We are excited to share this news with you as it expands our range of services and enhances our ability to meet your needs.
Veranex is the first concept-to-commercialization global service provider built for medical technology innovators. The Veranex platform is designed to provide the global medical technology industry with comprehensive, integrated, and technology-enabled product development and commercialization solutions.
Veranex brings together four complementary solution providers: Ximedica, Quartesian, Experien Group, and Boston Healthcare Associates. Bringing these companies together combines design and engineering, clinical development, regulatory, commercial strategy, and market access into a single-source solution.
The combined company brings deep experience in the areas of devices, in vitro diagnostics, precision medicine, digital health, and combination products/drug delivery among many other technology areas. Disease areas of focus include cardiovascular, orthopedic, women’s health, wound care, ophthalmology, neurology, oncology, and gastrointestinal among many others.
Veranex combines product development, regulatory, and market access expertise — globally in established and emerging markets — to help clients achieve their innovation objectives, accelerating time to market and optimizing clinical adoption and patient access.
For more information do not hesitate to contact us.